{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:02:34Z","timestamp":1790240554281,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.thromres.2026.109812","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:18:16Z","timestamp":1787325496000},"page":"109812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Subclinical carotid atherosclerosis in patients with retinal vein occlusion: Differential cardiovascular risk profiles"],"prefix":"10.1016","volume":"265","author":[{"given":"Zaida","family":"Salmon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"De la Roz Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Alonso-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Cerver\u00f3","family":"Varona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Gonz\u00e1lez-Mesones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"L\u00f3pez-Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor Manuel","family":"Mart\u00ednez-Taboada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2026.109812_bb0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.thromres.2026.109812_bb0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ophtha.2006.06.061","article-title":"Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts","volume":"114","author":"Cugati","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.thromres.2026.109812_bb0015","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.oret.2025.05.005","article-title":"Risk of adverse systemic events in retinal vein occlusion","volume":"9","author":"Albrecht","year":"2025","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.thromres.2026.109812_bb0020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2004.10.039","article-title":"Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities and Cardiovascular Health studies","volume":"112","author":"Wong","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.thromres.2026.109812_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.hipert.2018.12.004","article-title":"Hypertension and Framingham general vascular risk score in retinal vein occlusion","volume":"36","author":"Lisa Gracia","year":"2019","journal-title":"Hipertens. Riesgo Vasc."},{"key":"10.1016\/j.thromres.2026.109812_bb0030","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1167\/iovs.08-1826","article-title":"Traditional and novel cardiovascular risk factors for retinal vein occlusion: the Multi-Ethnic Study of Atherosclerosis","volume":"49","author":"Cheung","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.thromres.2026.109812_bb0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1160\/TH09-05-0331","article-title":"Coagulation disorders and the risk of retinal vein occlusion","volume":"103","author":"Kuhli-Hattenbach","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109812_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14082826","article-title":"Impact of the 2023 ACR\/EULAR antiphospholipid syndrome criteria on retinal vein occlusion patients","volume":"14","author":"G\u00e1lvez-S\u00e1nchez","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2026.109812_bb0045","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2026.109812_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14192162","article-title":"Impact of the 2023 ACR\/EULAR classification criteria in women with primary antiphospholipid syndrome during pregnancy","volume":"14","author":"Mart\u00ednez-Taboada","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.thromres.2026.109812_bb0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00296-025-06050-8","article-title":"Antiphospholipid antibodies and atherosclerotic vascular disease: recent advances","volume":"45","author":"Undas","year":"2025","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.thromres.2026.109812_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10111790","article-title":"Oxidative stress in the pathogenesis of antiphospholipid syndrome: implications for the atherothrombotic process","volume":"10","author":"Nocella","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.thromres.2026.109812_bb0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0003319719878582","article-title":"Carotid intima-media thickness versus carotid plaque burden for predicting cardiovascular risk","volume":"71","author":"Paraskevas","year":"2020","journal-title":"Angiology"},{"key":"10.1016\/j.thromres.2026.109812_bb0070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.23736\/S0392-9590.25.05386-6","article-title":"Cardiovascular disease risk categories based on SCORE algorithms and age: reclassification based on number of carotid and common femoral bifurcations with plaque","volume":"44","author":"Nicolaides","year":"2025","journal-title":"Int. Angiol."},{"key":"10.1016\/j.thromres.2026.109812_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030974","article-title":"Subclinical carotid atherosclerosis in patients with rheumatoid arthritis at low cardiovascular risk","volume":"11","author":"Gerasimova","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.thromres.2026.109812_bb0080","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X241302667","article-title":"SCORE2 is superior to SCORE in predicting the presence of carotid plaques and intima-media thickness in rheumatoid arthritis patients: a cross-sectional study using carotid ultrasound","volume":"16","author":"Campos Fern\u00e1ndez","year":"2024","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.thromres.2026.109812_bb0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.thromres.2020.04.005","article-title":"Antiphospholipid syndrome and antiphospholipid antibody profile in patients with retinal vein occlusion","volume":"190","author":"Hern\u00e1ndez","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109812_bb0090","doi-asserted-by":"crossref","first-page":"11905","DOI":"10.1038\/s41598-021-91401-1","article-title":"Clinical significance of subclinical atherosclerosis in retinal vein occlusion","volume":"11","author":"Lyu","year":"2021","journal-title":"Sci. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2026.109812_bb0095","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.thromres.2026.109812_bb0100","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2026.109812_bb0105","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","article-title":"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions","volume":"42","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2026.109812_bb0110","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2026.109812_bb0115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2026.109812_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hcv088","article-title":"The role of coagulation disorders in patients with retinal vein occlusion","volume":"109","author":"Napal","year":"2016","journal-title":"QJM"},{"key":"10.1016\/j.thromres.2026.109812_bb0125","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0037-1616130","article-title":"Thrombophilic risk factors in patients with central retinal vein occlusion","volume":"86","author":"Marcucci","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109812_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0953-6205(02)00025-0","article-title":"Cardiovascular and thrombophilic risk factors for central retinal vein occlusion","volume":"13","author":"Prisco","year":"2002","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.thromres.2026.109812_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/112067210801800211","article-title":"Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion","volume":"18","author":"Sodi","year":"2008","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.thromres.2026.109812_bb0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2012.06.053","article-title":"A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion","volume":"224","author":"Cellai","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2026.109812_bb0145","first-page":"341","article-title":"Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis","volume":"20","author":"Paciullo","year":"2022","journal-title":"Blood Transfus."},{"key":"10.1016\/j.thromres.2026.109812_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02713680701851902","article-title":"Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities","volume":"33","author":"Rehak","year":"2008","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.thromres.2026.109812_bb0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40942-024-00606-9","article-title":"Is retinal vein occlusion highly associated with an increased risk of myocardial infarction? A systematic review and meta-analysis","volume":"10","author":"Chen","year":"2024","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.thromres.2026.109812_bb0160","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/eurheartj\/ehad260","article-title":"SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe","volume":"44","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2026.109812_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2018.06.010","article-title":"Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: a cross-sectional study","volume":"274","author":"Di Minno","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2026.109812_bb0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2018.09.010","article-title":"The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies","volume":"278","author":"Di Minno","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2026.109812_bb0175","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.dib.2018.06.083","article-title":"Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies","volume":"19","author":"Di Minno","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/j.thromres.2026.109812_bb0180","first-page":"160","article-title":"Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus","volume":"149","author":"Lopez-Pedrera","year":"2017","journal-title":"Med. Clin. (Engl. Ed.)."},{"key":"10.1016\/j.thromres.2026.109812_bb0185","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.semarthrit.2017.10.015","article-title":"Carotid and femoral atherosclerosis in antiphospholipid syndrome: equivalent risk with diabetes mellitus in a case-control study","volume":"47","author":"Kravvariti","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.thromres.2026.109812_bb0190","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1093\/rheumatology\/keab882","article-title":"Atherosclerosis progression in antiphospholipid syndrome is comparable to diabetes mellitus: a 3-year prospective study","volume":"61","author":"Evangelatos","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.thromres.2026.109812_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101672","article-title":"Risk of subclinical atherosclerosis in patients with antiphospholipid syndrome and subjects with antiphospholipid antibody positivity: a systematic review and meta-analysis","volume":"48","author":"Karakasis","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.thromres.2026.109812_bb0200","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.rce.2013.01.012","article-title":"Trombofilia y factores de riesgo vascular en la obstrucci\u00f3n venosa retiniana","volume":"213","author":"Napal Lecumberri","year":"2013","journal-title":"Rev. Clin. Esp."},{"key":"10.1016\/j.thromres.2026.109812_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190568","article-title":"Carotid ultrasound is useful for the cardiovascular risk stratification in patients with hidradenitis suppurativa","volume":"13","author":"Gonz\u00e1lez-L\u00f3pez","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2026.109812_bb0210","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/annrheumdis-2012-203101","article-title":"Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study","volume":"73","author":"Corrales","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2026.109812_bb0215","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1136\/annrheumdis-2013-203433","article-title":"The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease","volume":"73","author":"Eder","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2026.109812_bb0220","article-title":"Role of increased lipoprotein(a) in retinal vein occlusion: a systematic review and meta-analysis","volume":"5","author":"Paciullo","year":"2021","journal-title":"TH Open."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826002318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826002318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:18:17Z","timestamp":1790237897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826002318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"alternative-id":["S0049384826002318"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109812","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclinical carotid atherosclerosis in patients with retinal vein occlusion: Differential cardiovascular risk profiles","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109812"}}